Other
Accounts Receivable, after Allowance for Credit Loss
Moderna Accounts Receivable, after Allowance for Credit Loss decreased by 61.4% to $71.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.0%, from $78.00M to $71.00M. Over 3 years (FY 2022 to FY 2025), Accounts Receivable, after Allowance for Credit Loss shows a downward trend with a -49.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2022
Last reportedQ1 2026May 1, 2026
How to read this metric
Rapid growth relative to sales may indicate collection issues or aggressive revenue recognition, while stability suggests healthy cash conversion cycles.
Detailed definition
The amount owed to the company by customers for goods or services delivered on credit, net of an allowance for estimated...
Peer comparison
Highly dependent on industry-standard payment terms and customer credit quality.
Metric ID:
other_accounts_receivable_netHistorical Data
12 periods
| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.39B | $1.87B | $892.00M | $137.00M | $163.00M | $1.56B | $358.00M | $78.00M | $36.00M | $1.05B | $184.00M | $71.00M |
| QoQ Change | — | +34.7% | -52.2% | -84.6% | +19.0% | +859.5% | -77.1% | -78.2% | -53.8% | >999% | -82.4% | -61.4% |
| YoY Change | — | — | -35.6% | — | — | -16.2% | -59.9% | -43.1% | -77.9% | -33.1% | -48.6% | -9.0% |
Range$36.00M – $1.87B
CAGR-66.1%
Avg YoY Growth-40.4%
Median YoY Growth-39.3%
Current Streak2 quarters decline
Accounts Receivable, after Allowance for Credit Loss at Other Companies
Frequently Asked Questions
- What is Moderna's accounts receivable, after allowance for credit loss?
- Moderna (MRNA) reported accounts receivable, after allowance for credit loss of $71.00M in Q1 2026.
- How has Moderna's accounts receivable, after allowance for credit loss changed year-over-year?
- Moderna's accounts receivable, after allowance for credit loss decreased by 9.0% year-over-year, from $78.00M to $71.00M.
- What is the long-term trend for Moderna's accounts receivable, after allowance for credit loss?
- Over 3 years (2022 to 2025), Moderna's accounts receivable, after allowance for credit loss has grown at a -49.0% compound annual growth rate (CAGR), from $1.39B to $184.00M.
- What does accounts receivable, after allowance for credit loss mean?
- Money owed to the company by customers, minus expected bad debts.